Application Notes Supplement 20212SHARES Share via Pinterest Reddit Buffer Xing WhatsApp FlipboardPosted: 21 December 2021 | European Pharmaceutical Review | No comments yetHere, industry experts from bioMérieux Industry, Charles River, Shimadzu, TA Instruments, Thermo Fisher Scientific and WITec share their research, guidance and pharmaceutical knowledge. Welcome to European Pharmaceutical Review’s Application Notes Supplement, December 2021.In this edition:bioMérieux Industry covers BIOBALL® Burkholderia cepacian complex strains performance testing for USP <60> growth promotion requirementsCharles River discusses taxonomic traceability for bacterial and fungal entries in Accugenix® reference databasesShimadzu covers comprehensive fractionation of herbal medicine components by PDA-ELSD-triggered preparative LCTA Instruments looks at an alternative method of drug‑excipient characterisationThermo Fisher Scientific explores how to achieve complete lab access with extended reality LIMS softwareWITec cover analysing pharmaceutical tablets with confocal Raman imagingRead NowIssueIssue 6 2021Related topicsAnalytical techniques, Excipients, Formulation, Herbal & Plant-Based Medicines, Informatics, Ingredients, Laboratory Information Management Systems (LIMS), Microbial Detection, Microbiology, Raman Spectroscopy, Technology, TherapeuticsRelated organisationsbioMérieux Industry, Charles River, Shimadzu, TA Instruments, Thermo Fisher Scientific, WITec GmbH
newsFDA approves novel therapy for chronic skin conditionBy Catherine Eckford (European Pharmaceutical Review)
newsEli Lilly releases topline data for new oral GLP-1By Catherine Eckford (European Pharmaceutical Review)
newsNew drug delivery method for cell therapies reportedBy Catherine Eckford (European Pharmaceutical Review)
newsEuropean Commission Alzheimer’s drug approval marks advancement for EU patientsBy Catherine Eckford (European Pharmaceutical Review)